Boston Scientific (BSX) Director Zane Ellen M Receives Award

What Happened Zane Ellen M, a director of Boston Scientific Corporation (BSX), was granted 3,800 shares of restricted stock on 2026-05-07 (transaction code A — award/grant). The Form 4 shows the shares were acquired at $0.00 (standard for awards); the filing notes the award reflects a value of $215,000 based on the closing stock price on the grant date (implied per-share value ≈ $56.58).

Key Details

• Transaction date: 2026-05-07; Form 4 filed: 2026-05-11.
• Type: Award/Grant (code A); Shares acquired: 3,800; Acquisition price shown: $0.00.
• Reported valuation: $215,000 (per footnote, derived from closing price on grant date).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: Annual equity award in the form of restricted stock that vests in full upon the next annual meeting of stockholders.
• No indication in the excerpt that this was part of a 10b5-1 plan or involved tax withholding; filing timeliness not marked as late in the provided data.

Context This was a routine director equity award (restricted stock) rather than an open-market purchase or sale. Restricted shares typically vest over time or upon a specified event (here, vesting in full at the next annual meeting), so the grant does not represent an immediate change in market exposure. Awards like this are common as part of director compensation and are informational rather than a direct trading signal.